Mannkind (MNKD) EBITDA (2010 - 2026)
Mannkind (MNKD) posted EBITDA of $6.05 million for Q2 2026, down 18.1% from $7.39 million a year earlier but up 28.3% from the prior quarter.
Powered by 
Analysis
Mannkind (MNKD) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Mannkind was $30.06 million, down 60.1% year-over-year; for FY2025, it came in at $51.09 million, down 36.1% from FY2024.
- In prior years, Mannkind's EBITDA was $79.96 million in FY2024 (+505.1%), $13.21 million in FY2023, -$60.79 million in FY2022 and -$45.04 million in FY2021.
- Quarterly EBITDA has run from a low of -$24.98 million in Q4 2021 to a high of $28.66 million in Q4 2024 over five years.
- On a year-over-year basis, EBITDA increased in four of the last seven quarters, with growth averaging 39.3%.
- The strongest year-over-year quarter for EBITDA in the past five years was Q2 2024, with growth of 524.1%; the weakest was Q1 2026, with a decline of 80.7%.
- According to Business Quant data, EBITDA for the three prior quarters was $4.72 million (Q1 2026), -$1.66 million (Q4 2025) and $20.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Mannkind | 1.04 Bn | 358.85 Mn | 94.97 Mn | 6.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.05 Mn |
| Mar 31, 2026 | 4.72 Mn |
| Dec 31, 2025 | -1.66 Mn |
| Sep 30, 2025 | 20.96 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Mar 31, 2025 | 24.40 Mn |
| Dec 31, 2024 | 28.66 Mn |
| Sep 30, 2024 | 14.88 Mn |
| Jun 30, 2024 | 18.34 Mn |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2023 | 9.08 Mn |
| Sep 30, 2023 | 6.13 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | -4.94 Mn |
| Dec 31, 2022 | -11.77 Mn |
| Sep 30, 2022 | -8.63 Mn |
| Jun 30, 2022 | -19.73 Mn |
| Mar 31, 2022 | -20.66 Mn |
| Dec 31, 2021 | -24.98 Mn |
| Sep 30, 2021 | -5.27 Mn |
API Access
Mannkind EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MNKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MNKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MNKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();